Pharma Execs Admit: ‘Our Model Is Broken’
March 28, 2012 As if we didn’t already know this, yes? Still, a new survey finds that 68 percent of pharma execs agree that Humpty Dumpty has fallen off the wall. To be specific, 44 percent agree that the pharma industry model is broken and 24 percent strongly agree with this statement. Another 22 percent are neutral and 6 percent disagree. We wonder where this 28 percent is working right now…
And over the next two years, 76 percent believe the healthcare system pricing and budget pressures will be the biggest challenge; followed by 70 percent who believe they will have to demonstrate cost effectiveness; 69 percent who cite more restrictive market access; 60 percent who fear generic competition; 53 percent who worry about less access to docs and 50 percent who are concerned about the ability of patients to pay for their meds.
The survey canvassed 156 pharma execs who either influence or have responsibility for sales and marketing at big drugmakers in the US and Europe. On average, they have held their jobs for five years and 52 percent are directors, with 15 percent say they are vp’s and 20 percent identifying as managers. Most are responsible for a product portfolio, 46 percent, or a specific brand, 33 percent.
Read More:
http://www.pharmalot.com/2012/03/pharma-execs-admit-our-model-is-broken/
